<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T13:35:37Z</responseDate>
  <request identifier="oai:figshare.com:article/34046307" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34046307</identifier>
        <datestamp>2026-10-01T14:21:47Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Benchmarking
Glycoproteomics Software Using Diagnostic
Ion Based Post-Validation for Glycopeptide Identification</dc:title>
          <dc:creator>Hiroaki Sakaue (1694350)</dc:creator>
          <dc:creator>Kunio Kawanishi (24554681)</dc:creator>
          <dc:creator>Azusa Tomioka (1364766)</dc:creator>
          <dc:creator>Chiaki Nagai-Okatani (2818309)</dc:creator>
          <dc:creator>Hiroyuki Kaji (505920)</dc:creator>
          <dc:creator>Atsushi Kuno (7003)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>warranted cautious interpretation</dc:subject>
          <dc:subject>sialic acid synthesis</dc:subject>
          <dc:subject>rare glycan structures</dc:subject>
          <dc:subject>program enabled comprehensive</dc:subject>
          <dc:subject>identical data sets</dc:subject>
          <dc:subject>highly branched glycans</dc:subject>
          <dc:subject>grable ), investigating</dc:subject>
          <dc:subject>compared five state</dc:subject>
          <dc:subject>improved glycopeptide identification</dc:subject>
          <dc:subject>glycopeptide identification advancements</dc:subject>
          <dc:subject>diagnostic oxonium ions</dc:subject>
          <dc:subject>specific criteria based</dc:subject>
          <dc:subject>identify rare neugc</dc:subject>
          <dc:subject>grable identified complex</dc:subject>
          <dc:subject>glycopeptide identifications even</dc:subject>
          <dc:subject>combining software programs</dc:subject>
          <dc:subject>y1 ions provides</dc:subject>
          <dc:subject>glycopeptide identification</dc:subject>
          <dc:subject>specific programs</dc:subject>
          <dc:subject>based filtering</dc:subject>
          <dc:subject>weaker evidence</dc:subject>
          <dc:subject>spectral evidence</dc:subject>
          <dc:subject>robustly supported</dc:subject>
          <dc:subject>reliable analysis</dc:subject>
          <dc:subject>limiting enzyme</dc:subject>
          <dc:subject>lack udp</dc:subject>
          <dc:subject>k20 cells</dc:subject>
          <dc:subject>individual tools</dc:subject>
          <dc:subject>independent spectrum</dc:subject>
          <dc:subject>identifications retained</dc:subject>
          <dc:subject>glycoproteomics software</dc:subject>
          <dc:subject>complementary strengths</dc:subject>
          <dc:subject>approximately one</dc:subject>
          <dc:subject>acetylglucosamine 2</dc:subject>
          <dc:description>Advancements in glycoproteomics software have improved
glycopeptide
identification. However, algorithmic differences cause discrepancies
in glycopeptide identifications even when identical data sets are
used. We compared five state-of-the-art glycoproteomics software programs
(Byonic, MSFragger-Glyco, pGlyco3, Glyco-Decipher, and GRable), investigating
their ability to identify rare NeuGc- and KDN-containing glycopeptides
from BJAB-K20 cells, which lack UDP-N-acetylglucosamine 2-epimerase,
the rate-limiting enzyme for sialic acid synthesis. Approximately
one-third of the identified glycopeptides were unique to individual
tools. Byonic identified the most glycopeptides, whereas Glyco-Decipher
and GRable identified complex, highly branched glycans. NeuGc- and
KDN-containing glycopeptides were identified by specific programs,
highlighting their ability to handle rare glycan structures. To assess
the reliability of these identifications, we reanalyzed the MS/MS
spectra and stratified all identifications retained under the software-specific
criteria based on spectral evidence from diagnostic oxonium ions and
Y0/Y1 or b/y ions. Although most were robustly supported, some relied
on weaker evidence and warranted cautious interpretation. Leveraging
the capabilities of each program enabled comprehensive, reliable analysis
of glycopeptides with rare glycan structures. Combining software programs
with complementary strengths and systematic postvalidation using diagnostic
oxonium ions and Y0/Y1 ions provides an independent spectrum-level
confidence assessment beyond conventional FDR-based filtering, improving
the reliability and depth of glycopeptide identification.</dc:description>
          <dc:date>2026-10-01T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.jproteome.6c00345.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Benchmarking_Glycoproteomics_Software_Using_Diagnostic_Ion_Based_Post-Validation_for_Glycopeptide_Identification/34046307</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
